CNSP · ISSUER CIK 1729427
CNS Pharmaceuticals, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 CNS Pharmaceuticals, Inc. insiders reported $10K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Fisher Michal (Director), with $10K.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$10KInsider buying
$0.00Insider selling
+$10KNet open-market
Aug 18, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 202609:01 | May 18, 2026 | CNSP | Director | P · BuyLate 92d | $5.00 | +2,000 | 2,000 | New | +$10K | -36.2% | -4.6% |
| Aug 18, 202609:00 | Aug 14, 2026 | CNSP | CEO and President | M · Exercise | — | −4,750 | 4,750 | -50% | — |